Analogic Launches LIFEGARD II Non-Invasive Patient Monitors

Analogic’s new LIFEGARD II patient monitors come in four versions, some with ICG (Impedance CardioGraphy) and/or CO2 specifications. Thoracic Electrical Bioimpedance (TEB) is used to measure continuous cardiac output. As non-invasive, portable devices, they provide comprehensive and versatile hemodynamic monitoring even in non-acute environments such as doctors’ offices. With a 3- to 4-hour battery life, these products are adapted to patient transport. And unlike conventional invasive tools, non-invasive monitoring is quick and pose no risk of infections. The Lifegard II range covers general-purpose monitoring needs as well as some specialty needs related to advanced hemodynamics and patient ventilation.

Parameters measured:

  • Continuous Cardiac Output - ICG (Impedance Cardiography) to calculate 17 hemodynamic values
  • Continuous airway CO2 and airway breath rate
  • ECG - 3-lead acquisition with pacemaker detection
  • Heart Rate - Detected via ECG, SpO2, or NIBP
  • Respiration - Transthoracic impedance
  • Pulse Oximetry - Nellcor-compatible with selectable response modes including “Sat Seconds” alarm management
  • Blood Pressure - manual, automatic, and stat modes supported by an indicator for elapsed time since last measurement
  • Temperature - YSI Series 400 compatible thermistor probes

Source:
Press release
and data sheet.

March 8, 2006 Related topics: Product Launches, Monitoring

Today on
Hospital Buyer

HospitalBuyer Undergoing Surgery

HospitalBuyer is on long-term hiatus. We may come back in new and improved form in the future, but...

CT Scans Alter ER Decision-Making About Appendicitis

Data collected from CT scanning of the abdomen and pelvis can alter decision-making by clinicians regarding those patients...

MediNotes Purchase Completed by Eclipsys

Eclipsys Corporation announced that the acquisition (pdf) of MediNotes was finalized. MediNotes is now a wholly owned subsidiary...

http://www.hospitalbuyer.com